Annemiek J. de Boer

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.

Alexander B. H. Bakker, Marco W.J. Schreurs, Annemiek J. de Boer et al. · The Journal of Experimental Medicine · 1994 · 584 citations · Full text

Life Sciences, Immunology, Oncology +17

Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

Andreas A. O. Eggert, Marco W.J. Schreurs, Otto C. Boerman et al. · PubMed · 1999 · 281 citations

Medicine, Immunology, Oncology +17

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp et al. · Clinical Cancer Research · 2015 · 235 citations · Full text

Medicine, Immunology, Oncology +17

Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

E. van de Wiel-van Kemenade, M J Ligtenberg, Annemiek J. de Boer et al. · The Journal of Immunology · 1993 · 222 citations · Full text

Medicine, Immunology, Oncology +14

Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt et al. · Clinical Cancer Research · 2011 · 191 citations · Full text

Medicine, Immunology, Oncology +17